Intrarenal renin-angiotensin system

Molecular and Cellular Endocrinology

Volumn 302, Issue 2, 2009, Pages 185-192

  Rosivall, László ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Intrarenal RAS; Juxtaglomerular apparatus; Prorenin; Renin secretion

Indexed keywords

ALDOSTERONE; AMINOPEPTIDASE; AMINOPEPTIDASE B; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; GAP JUNCTION PROTEIN; GLUTAMYL AMINOPEPTIDASE; LOOP DIURETIC AGENT; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR; PRORENIN; RECEPTOR; RENIN; SODIUM CHLORIDE;

ARTERIOLE; CELL FUNCTION; CELL PROLIFERATION; ENZYME ACTIVITY; GLOMERULUS; IMAGING; IN VIVO STUDY; INFLAMMATION; JUXTAGLOMERULAR APPARATUS; KIDNEY BLOOD FLOW; KIDNEY TUBULE; MORPHOLOGY; NONHUMAN; ONTOGENY; PATHOPHYSIOLOGY; PHYLOGENY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM ABSORPTION; VASOCONSTRICTION; WATER METABOLISM;

ANIMALS; CELL COMMUNICATION; HUMANS; JUXTAGLOMERULAR APPARATUS; KIDNEY; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 62949192627     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.09.033     Document Type: Review

References (96)

1. Antus B., Exton M.S., and Rosivall L. Angiotensin II: a regulator of inflammation during renal disease?. Int. J. Immunopathol. Pharmacol. 14 1 (2001) 25-30
2. Antus B., Mucsi I., and Rosivall L. Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible implication and perspectives. Acta Physiol. Hung. 87 1 (2000) 5-24
3. Bader M., and Ganten D. Update on tissue renin-angiotensin systems. J. Mol. Med. 86 6 (2008) 615-621
4. Bailie M.D., Donoso V.S., and Porter T.M. Urinary excretion of renin in the dog: effect of changes in plasma renin. J. Pharmacol. Exp. Ther. 225 2 (1983) 366-371
5. Banday A.A., and Lokhandwala M.F. Oxidative stress-induced renal angiotensin AT1 receptor upregulation causes increased stimulation of sodium transporters and hypertension. Am. J. Physiol. Renal Physiol. (2008) 10.1152/ajprenal.90308.2008
6. Bell P.D., Lapointe J.Y., and Peti-Peterdi J. Macula densa cell signaling. Annu. Rev. Physiol. 65 (2003) 481-500
7. Birbari A. Intrarenal factors in the control of renin secretion. Pflügers Arch. 337 (1972) 29-37
8. Burcklé C.A., Danser A.H.J., Müller D.N., Garrelds I.M., Gasc J.M., Popova E., Plehm R., Peters J., Bader M., and Nguyen G. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 47 3 (2006) 552-556
9. Carey R.M., and Padia S.H. Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure. Trends Endocrinol. Metab. 19 3 (2008) 84-87
10. Chen L., Kim S.M., Oppermann M., Faulhaber-Walter R., Huang Y., Mizel D., Chen M., Lopez M.L., Weinstein L.S., Gomez R.A., Briggs J.P., and Schnermann J. Regulation of renin in mice with Cre recombinase-mediated deletion of G protein Gsalpha in juxtaglomerular cells. Am. J. Physiol. Renal Physiol. 292 1 (2007) F27-F37
11. Chen Y., Lasaitiene D., and Friberg P. The renin-angiotensin system in kidney development. Acta Physiol. Scand. 181 4 (2004) 529-535
12. Chappel M.C., and Ferrario C.M. ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7). Kidney Int. 70 1 (2006) 8-10
13. Dandona P., Dhindsa S., Ghanim H., and Ghaudhuri A. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J. Human Hypertension 21 (2007) 20-27
14. Danser A.H.J., and Deinum J. Renin, prorenin and the putative (pro)renin receptor. Hypertension 46 5 (2005) 1069-1076
15. Danser A.H.J., Derkx F.H.M., Schalekamp M.A.D.H., Hensec H.-W., Riegger G.A.J., and Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J. Hypertension 16 (1998) 853-862
16. Dzau V.J. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation. 77 6 Pt 2 (1988) I4-I3
17. Essig M., and Friedlander G. Shear-stress-responsive signal transduction mechanisms in renal proximal tubule cells. Curr. Opin. Nephrol. Hypertens. 12 1 (2003) 31-34
18. Essig M., Terzi F., Burtin M., and Friedlander G. Mechanical strains induced by tubular flow affect the phenotype of proximal tubular cells. Am. J. Physiol. Renal Physiol. 281 4 (2001) F751-F762
19. Fintha A., Sebe A., Masszi A., Terebessy T., Huszár T., Rosivall L., and Mucsi I. Angiotensin II activates plasminogen activator inhibitor-I promoter in renal tubular epithelial cells via the AT1 receptor. Acta Physiol. Hung. 94 1-2 (2007) 19-30
20. Frederiksen O., Leyssac P.P., and Skinner S.L. Sensitive osmometer function of juxtaglomerular cells in vitro. J. Physiol. 252 (1975) 669-679
21. Ganten D., Mullins J., and Lindpaintner K. The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors. J. Human Hypertens. Suppl. 1 (1989) 63-70
22. Gociman B., Rohrwasser A., Lantelme P., Cheng T., Hunter G., Monson S., Hunter J., Hillas E., Lott P., Ishigami T., and Lalouel J.M. Expression of angiotensinogen in proximal tubule as a function of glomerular filtration rate. Kidney Int. 65 6 (2004) 2153-2160
23. Golgi C. Annotazioni intorno all' Istologia dei reni dell'uomo e di altri mammiferi e sull' Istogenesi canalicoli oriniferi. Atti R. Accad. d. Lincei, Rend. Ser. 4 5 (1889) 334-342
24. Gomez R.A., Lynch K.R., Sturgill B.C., Elwood J.P., Chevalier R.L., Carey R.M., and Peach M.J. Distribution of renin mRNA and its protein in the developing kidney. Am. J. Physiol. 257 5 Pt 2 (1989) F850-F858
25. 2+-permeable nonselective channel. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 1182-1187
26. Goormaghtigh N. L'appreil neuromyo-arteriel juxtaglomerulaire durein; ses reactions en pathologie et ses rapports avec le tube urinifere. C. R. Soc. Biol. 124 (1937) 293-296
27. Hanaoka K., Qian F., Boletta A., Bhunia A., Piontek K., Tsiokas L., Sukhatme V.P., Guggino W.B., and Germino G.G. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 408 (2000) 990-994
28. Hanner F., Chambrey R., Bourgeois S., Meer E., Mucsi I., Rosivall L., Shull G.E., Lorenz J.N., Eladari D., and Peti-Peterdi J. Increased renal renin content in mice lacking the Na+/H+ exchanger NHE2. Am. J. Physiol. Renal Physiol. 294 4 (2008) F937-F944
29. Hanner, F., von Maltzahn, J., Maxeiner, S., Toma, I, Sipos, A., Kruger, O., Willecke, K., Peti-Peterdi, J., 2008. Connexin45 is expressed in the juxtaglomerular apparatus and is involved in the regulation of renin secretion and blood pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. [Epub ahead of print].
30. He Weihai, Miao Frederick J.-P., Lin Daniel C.-H., Schwandner Ralf T., Wang Zhulun, Gao Jinhai, Chen Jin-Long, Tian Hui, Ling Lei. 2004. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature, 429, 188-193.
31. Holdsworth S., McLean A., Morris B.J., Dax E., and Johnston C.I. Renin release from isolated rat glomeruli. Clin. Sci. Mol. Med. Suppl. 3 (1976) 97s-99s
32. Hwang S.K., and Beyer E.C. Heterogenous localization of connexin 40 in the renal vasculature. Microvasc. Res. 59 (2000) 140-148
33. Ichihara A., Kaneshiro Y., Takemitsu T., Sakoda M., Nakagawa T., Nishiyama A., Kawachi H., Shimizu F., and Inagami T. Contribution of non-proteolytically activated prorenin in glomeruli to hypertensive renal damage. J. Am. Soc. Nephrol. 17 (2006) 2495-2503
34. Ichihara A., Suzuki F., Nakagawa T., Kaneshiro Y., Takemitsu T., Sakoda M., Nabi A.H.M.N., Nishiyama A., Sugaya T., Hayashi M., and Inagami T. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor deficient mice. J. Am. Soc. Nephrol. 17 (2006) 1950-1961
35. Jensen B.L., and Skøtt O. Osmotically sensitive renin release from permeabilized juxtaglomerular cells. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 265 (1993) F87-F95
36. Kaneshiro Y., Ichihara A., Takemitsu T., Sakoda M., Suzuki F., Nakagawa T., Hayashi M., and Inagami T. Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int. 70 4 (2006) 641-646
37. Kang J.J., Toma I., Sipos A., Meer E.J., Vargas S.L., and Peti-Peterdi J. The collecting duct is the major source of prorenin in diabetes. Hypertension 51 6 (2008) 1597-1604
38. Kobori H., Nangaku M., Navar L.G., and Nishiyama A. The Intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol. Rev. 59 (2007) 251-287
39. Kobori H., Nishiyama A., Harrison-Bernard L.M., and Navar L.G. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 41 1 (2003) 42-49
40. Kobori H., Katsurada A., Miyata K., Ohashi N., Satou R., Saito T., Hagiwara Y., Miyashita K., and Navar L.G. Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA. Am. J. Physiol. Renal Physiol. 294 5 (2008) F1257-F1263
41. Kopp U.C., and DiBona G.F. Effects of physiological increments in renal arterial plasma osmolarity on renin secretion rate. J. Lab. Clin. Med. 102 (1983) 250-259
42. Kovács G., Peti-Peterdi J., Rosivall L., and Bell P.D. Angiotensin II directly stimulates macula densa Na-2Cl-K cotransport via apical AT(1) receptors. Am. J. Physiol. Renal Physiol. 282 2 (2002) F301-F306
43. Krop M., de Bruyn J.H., Derkx F.H., and Danser A.H. Renin and prorenin disappearance in humans post-nephrectomy: evidence for binding?. Front Biosci. 1 13 (2008) 3931-3939
44. Kumar R., Singh V.P., and Baker K.M. The intracellular renin-angiotensin system: implications in cardiovascular remodeling. Curr. Opin. Nephrol. Hypertens. 17 2 (2008) 168-173
45. Kurtz A., and Schweda F. Osmolarity-induced renin secretion from kidneys: evidence for readily releasable renin pools. Am. J. Physiol. Renal Physiol. 290 (2006) F797-F805
46. Kurtz L., Schweda F., de Wit C., Kriz W., Witzgall R., Warth R., Sauter A., Kurtz A., and Wagner C. Lack of connexin 40 causes displacement of renin-producing cells from afferent arterioles to the extraglomerular mesangium. J. Am. Soc. Nephrol. 18 (2007) 1103-1111
47. Lalouel J.M., and Rohrwasser A. Genetic susceptibility to essential hypertension: insight from angiotensinogen. Hypertension 49 3 (2007) 597-603
48. Lambert D.W., Hooper N.M., and Turner A.J. Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system. Biochem. Pharmacol. 75 4 (2008) 781-786
49. Lantelme P., Rohrwasser A., Gociman B., Hillas E., Cheng T., Petty G., Thomas J., Xiao S., Ishigami T., and Herrmann T. Effects of dietary sodium and genetic background on angiotensinogen and renin in mouse. Hypertension 39 (2002) 1007-1014
50. Loghman-Adham M., Soto C.E., Inagami T., and Cassis L. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am. J. Physiol. Renal Physiol. 287 (2004) F775-F788
51. Luetscher J.A., Kraemer F.B., Wilson D.M., Schwartz H.C., and Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus: A marker of microvascular complications. N. Engl. J. Med. 312 (1985) 1412-1417
52. Leyssac P.P. The renin-angiotensin system and kidney function-a review of contribution to a new theory. Acta Physiol. Scand. 442 Suppl. (1976) 1-52
53. Leyssac P.P. Micropuncture study of renin release at the single nephron level: Evidence for some release directly into the circulating blood. Renal Physiol. 1 (1979) 61-73
54. McPherson E.A., Luo Z., Brown R.A., Lebard L.S., Corless C.C., Speth R.C., and Bagby S.P. Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 15 (2004) 493-500
55. Mitchell K.D., Botros F.T., and Navar L.G. Intrarenal renin-angiotensin system and counteracting protective mechanisms in angiotensin II-dependent hypertension. Acta Physiol. Hung. 94 1-2 (2007) 31-48
56. Moore R., Krstew E.V., Kirchhoff J., Davisson R.L., and Lawrence A.J. Central overexpression of angiotensin AT(1A) receptors prevents dopamine D(2) receptor regulation of alcohol consumption in mice. Alcohol Clin. Exp. Res. 31 7 (2007) 1128-1137
57. Nauli S.M., Alenghat F.J., Luo Y., Williams E., Vassilev P., Li X., Elia A.E.H., Lu W., Brown E.M., Quinn S.J., Ingber D.E., and Zhou J. Polycystin 1, and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33 (2003) 129-137
58. Navar L.G., and Rosivall L. Contribution of the renin-angiotensin system to the control of renal hemodynamics. Kidney Int. 25 (1984) 857-868
59. Navar L.G., Lewis L., Hymel A., Braam B., and Mitchell K.D. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats. J. Am. Soc. Nephrol. 5 4 (1994) 1153-1158
60. Nguyen G., and Contrepas A. Physiology and pharmacology of the (pro)renin receptor. Curr. Opin. Pharmacol. 8 2 (2008) 127-132
61. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., and Sraer J.-D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109 (2002) 1417-1427
62. Paul M., Mehr A.P., and Kreutz R. Physiology of local renin-angiotensin systems. Physiol. Rev. 86 (2006) 747-803
63. Peti-Peterdi J., Fintha A., Fuson A.L., Tousson A., and Chow R.H. Real-time imaging of renin release in vitro. Am. J. Physiol. Renal Physiol. 287 2 (2004) F329-F335
64. Petrovic N., Black T.A., Fabian J.R., Kane C.M., Jones C.A., Loudon J.A., Abonia J.P., Sigmund C.D., and Gross K.W. Role of proximal promoter elements in regulation of renin gene transcription. J. Biol. Chem. 271 (1996) 22499-22505
65. Phillips M.I., and de Oliveira E.M. Brain renin angiotensin in disease. J. Mol. Med. 86 6 (2008) 715-722
66. Prieto-Carrasquero M.C., Harrison-Bernard L.M., Kobori H., Ozawa Y., Hering-Smith K.S., Hamm L.L., and Navar L.G. Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 44 (2004) 223-229
67. Rightsel W.A., Okamura T., Inagami T., Pitcock J.A., Takii Y., Brooks B., Brown P., and Muirhead E.E. Juxtaglomerular cells grown as monolayer cell culture contain renin, angiotensin I-converting enzyme, and angiotensin I and II/III. Circ. Res. 50 6 (1982) 822-829
68. Rohrwasser A., Morgan T., Dillon H.F., Zhao L., Callaway C.W., Hillas E., Zhang S., Cheng T., Inagami T., Ward K., et al. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 34 (1999) 1265-1274
69. Rosivall L. Intrarenal renin-angiotensin system and its contribution to the regulation of glomerular haemodynamics. Nephrol. Dial. Transplant. 10 9 (1995) 1565-1568
70. Rosivall L., Peti-Peterdi J., Rázga Z., Fintha A., Bodor C., and MirzaHosseini S. Renin-angiotensin system affects endothelial morphology and permeability of renal afferent arteriole. Acta Physiol. Hung. 94 1-2 (2007) 7-17
71. Rosivall L., Mirzahosseini S., Toma I., Sipos A., and Peti-Peterdi J. Fluid flow in the juxtaglomerular interstitium visualized in vivo. Am. J. Physiol. Renal Physiol. 291 6 (2006) F1241-F1247
72. Rosivall L., and Peti-Peterdi J. Heterogeneity of the afferent arteriole-correlations between morphology and function. Nephrol. Dial. Transplant. 21 10 (2007) 2703-2707
73. Rosivall L., and Taugner R. The morphological basis of fluid balance in the interstitium of the juxtaglomerular apparatus. Cell Tissue Res. 243 3 (1986) 525-533
74. Rosivall L., and Taugner R. Fluid balance in the interstitium of the Goomarghtigh cell field. In: Persson A.E.G., and Boberg U. (Eds). Juxtaglomerular apparatus and tubuloglomerular feedback mechanism. Fernström Foundation Series vol. 11 (1988), Elsevier Science Publisher, Amsterdam 39-50
75. Ruyter J.C. Uber einen Merkwürdigen Abschnitt der vasa Afferentia in der Mäuseniere. Z. Zellforsch. Mikrosk. Anat. 2 (1925) 242-248
76. Sarafidis P., Stafylas A., Panagiotis C., Aggeliki I.K., and Lasaridis N. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis. Am. J. Hypertens. 21 August (8) (2008) 922-929
77. Sarzani R., Salvi F., Dessì-Fulgheri P., and Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J. Hypertens. 26 5 (2008) 831-843
78. Schalekamp M.A., Derkx F.H., Deinum J., and Danser A.J. Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors. J. Hypertens. 26 5 (2008) 928-937
79. Schefe J.H., Menk M., Reinemund J., Effertz K., Hobbs R.M., Pandolfi P.P., Ruiz P., Unger T., and Funke-Kaiser H. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ. Res. 99 12 (2006) 1355-1366
80. Schweda F., Friis U., Wagner C., Skott O., and Kurtz A. Renin release. Physiology (Bethesda) 22 (2007) 310-319
81. Seikaly M.G., Arant Jr. B.S., and Seney Jr. F.D. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J. Clin. Invest. 86 4 (1990) 1352-1357
82. Sendra J., Llorente-Cortés V., Costales P., Huesca-Gómez C., and Badimon L. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension. Cardiovasc. Res. 78 3 (2008) 581-589
83. Sipos A., Toma I., Kang J.J., Rosivall L., and Peti-Peterdi J. Advances in renal (patho)physiology using multiphoton microscopy. Kidney Int. 72 10 (2007) 1188-1191
84. Terebessy T., Masszi A., Fintha A., Sebe A., Huszár T., Rosivall L., and Mucsi I. Angiotensin II activates the human renin promoter in an in vitro model: the role of c-Jun-N-terminal kinase. Nephrol. Dial. Transplant 19 9 (2004) 2184-2191
85. Tigerstedt R., and Bergman P.G. Niere und Kreislauf. Skand Arch. Physiol. 8 (1898) 223-271
86. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., and Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275 43 (2000) 33238-33243
87. Toma I., Kang J.J., Sipos A., Vargas S., Bansal E., Hanner F., Meer E., and Peti-Peterdi J. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J. Clin. Invest. 118 7 (2008) 2526-2534
88. Turner A.J., Tipnis S.R., Guy J.L., Rice G., and Hooper N.M. ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can. J. Physiol. Pharmacol. 80 4 (2002) 346-353
89. Twu B.M., Cannon M.E., and Hsu C.H. The role of osmolarity in renin release from afferent arterioles. J. Hypertens. 7 (1989) 757-761
90. Vander A.J., and Miller R. Control of renin secretion in the anesthetized dog. Am. J. Physiol. 207 (1964) 537-546
91. Villard E., Lalau J.D., van Hooft I.S., Derkx F.H., Houot A.M., Pinet F., Corvol P., and Soubrier F. A mutant renin gene in familial elevation of prorenin. J. Biol. Chem. 269 48 (1994) 30307-30312
92. Wagner C. Function of connexins in the renal circulation. Kidney Int. 73 (2008) 547-555
93. Wagner C., de Wit C., Kurtz L., Grünberger C., Kurtz A., and Schweda F. Connexin 40 is essential for the pressure control of renin synthesis and secretion. Circ. Res. 100 (2007) 556-563
94. Widdop R.E., Vinh A., Henrion D., and Jones E.S. Vascular angiotensin AT2 receptors in hypertension and ageing. Clin. Exp. Pharmacol. Physiol. 35 4 (2008) 386-390
95. Young L.D., and Rostorfer H.H. Renin release responses to acute alterations in renal arterial osmolarity. Am. J. Physiol. 225 (1973) 1009-1014
96. Zhou X.Y., Davis D.R., and Sigmund C.D. The human renin kidney enhancer is required to maintain base-line renin expression but is dispensable for tissue-specific, cell-specific, and regulated expression. J. Biol. Chem. 281 46 (2006) 35296-35304